Metabolism Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapy Type (Enzyme Replacement Therapy, Substrate Reduction Therapy, Small Molecule Drugs, Others); Application (Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism Disease, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00004056 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Metabolism is the process by which the human body converts the food they consume into an energy. Metabolism drugs are utilized to treat various metabolic disorders in the human body. Metabolic disorders include lipid metabolism disease, glycogen metabolism disease, metal metabolism disease, amino acid metabolism etc. Metabolic diseases are can also be genetic disorders. However, metabolic disorders are associated with obesity or overweight and inactivity.

MARKET SCOPE

The "Global Metabolism Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the metabolism drugs market with detailed market segmentation by therapy type, application and distribution channel. The report provides key statistics on the market status of the leading metabolism drugs market players and offers key trends and opportunities in the market.MARKET SEGMENTATION

  •   Based on therapy type the market is segmented as, enzyme replacement therapy, substrate reduction therapy, small molecule drugs, others.
  •   Based on application the market is segmented as, glycogen metabolism disease, lipid metabolism disease, amino acid metabolism disease, others.

MARKET DYNAMICS
Drivers:

  •   Growing prevalence of metabolllic disorders.
  •   Presence of various risk factors such as, obesity, unhealthy lifestyles, presence of comorbidities are expected to fuel the market growth.
  •   Rising awareness about treatment and diagnosis of various metabollic disorders.

Restraints:

  •   However, possibility of side effects from prolonged treatment therapy is expected to restrain market growth.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The metabolism drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the metabolism drugs market in these regions.

IMPACT OF COVID-19 ON METABOLISM DRUGS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the metabolism drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from metabolism drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for metabolism drugs in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the metabolism drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  •   Merck Sharp and Dohme Corp
  •   Novartis AG
  •   Amicus Therapeutics
  •   AstraZeneca
  •   Boehringer Ingelheim International GmbH
  •   Takeda Pharmaceutical Company Limited
  •   Sanofi
  •   GlaxoSmithKline Plc
  •   Horizon Therapeutics
  •   BioMarin Pharmaceutical
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Metabolism Drugs Market - By Therapy Type
    1.3.2 Metabolism Drugs Market - By Application
    1.3.3 Metabolism Drugs Market - By Distribution Channel
    1.3.4 Metabolism Drugs Market - By Region
    1.3.4.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. METABOLISM DRUGS MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PORTER'S FIVE FORCES ANALYSIS
    4.2.1 Bargaining Power of Buyers
    4.2.1 Bargaining Power of Suppliers
    4.2.1 Threat of Substitute
    4.2.1 Threat of New Entrants
    4.2.1 Competitive Rivalry
    4.3. EXPERT OPINIONS

    5. METABOLISM DRUGS MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. METABOLISM DRUGS MARKET - GLOBAL MARKET ANALYSIS
    6.1. METABOLISM DRUGS - GLOBAL MARKET OVERVIEW
    6.2. METABOLISM DRUGS - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. METABOLISM DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY TYPE
    7.1. OVERVIEW
    7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
    7.3. ENZYME REPLACEMENT THERAPY
    7.3.1. Overview
    7.3.2. Enzyme Replacement Therapy Market Forecast and Analysis
    7.4. SUBSTRATE REDUCTION THERAPY
    7.4.1. Overview
    7.4.2. Substrate Reduction Therapy Market Forecast and Analysis
    7.5. SMALL MOLECULE DRUGS
    7.5.1. Overview
    7.5.2. Small Molecule Drugs Market Forecast and Analysis
    7.6. OTHERS
    7.6.1. Overview
    7.6.2. Others Market Forecast and Analysis
    8. METABOLISM DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
    8.1. OVERVIEW
    8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    8.3. GLYCOGEN METABOLISM DISEASE
    8.3.1. Overview
    8.3.2. Glycogen Metabolism Disease Market Forecast and Analysis
    8.4. LIPID METABOLISM DISEASE
    8.4.1. Overview
    8.4.2. Lipid Metabolism Disease Market Forecast and Analysis
    8.5. AMINO ACID METABOLISM DISEASE
    8.5.1. Overview
    8.5.2. Amino Acid Metabolism Disease Market Forecast and Analysis
    8.6. OTHERS
    8.6.1. Overview
    8.6.2. Others Market Forecast and Analysis
    9. METABOLISM DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
    9.1. OVERVIEW
    9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
    9.3. HOSPITAL PHARMACIES
    9.3.1. Overview
    9.3.2. Hospital Pharmacies Market Forecast and Analysis
    9.4. RETAIL PHARMACIES
    9.4.1. Overview
    9.4.2. Retail Pharmacies Market Forecast and Analysis
    9.5. ONLINE PHARMACIES
    9.5.1. Overview
    9.5.2. Online Pharmacies Market Forecast and Analysis

    10. METABOLISM DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Metabolism Drugs Market Overview
    10.1.2 North America Metabolism Drugs Market Forecasts and Analysis
    10.1.3 North America Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
    10.1.4 North America Metabolism Drugs Market Forecasts and Analysis - By Application
    10.1.5 North America Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
    10.1.6 North America Metabolism Drugs Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Metabolism Drugs Market
    10.1.6.1.1 United States Metabolism Drugs Market by Therapy Type
    10.1.6.1.2 United States Metabolism Drugs Market by Application
    10.1.6.1.3 United States Metabolism Drugs Market by Distribution Channel
    10.1.6.2 Canada Metabolism Drugs Market
    10.1.6.2.1 Canada Metabolism Drugs Market by Therapy Type
    10.1.6.2.2 Canada Metabolism Drugs Market by Application
    10.1.6.2.3 Canada Metabolism Drugs Market by Distribution Channel
    10.1.6.3 Mexico Metabolism Drugs Market
    10.1.6.3.1 Mexico Metabolism Drugs Market by Therapy Type
    10.1.6.3.2 Mexico Metabolism Drugs Market by Application
    10.1.6.3.3 Mexico Metabolism Drugs Market by Distribution Channel
    10.2. EUROPE
    10.2.1 Europe Metabolism Drugs Market Overview
    10.2.2 Europe Metabolism Drugs Market Forecasts and Analysis
    10.2.3 Europe Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
    10.2.4 Europe Metabolism Drugs Market Forecasts and Analysis - By Application
    10.2.5 Europe Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
    10.2.6 Europe Metabolism Drugs Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Metabolism Drugs Market
    10.2.6.1.1 Germany Metabolism Drugs Market by Therapy Type
    10.2.6.1.2 Germany Metabolism Drugs Market by Application
    10.2.6.1.3 Germany Metabolism Drugs Market by Distribution Channel
    10.2.6.2 France Metabolism Drugs Market
    10.2.6.2.1 France Metabolism Drugs Market by Therapy Type
    10.2.6.2.2 France Metabolism Drugs Market by Application
    10.2.6.2.3 France Metabolism Drugs Market by Distribution Channel
    10.2.6.3 Italy Metabolism Drugs Market
    10.2.6.3.1 Italy Metabolism Drugs Market by Therapy Type
    10.2.6.3.2 Italy Metabolism Drugs Market by Application
    10.2.6.3.3 Italy Metabolism Drugs Market by Distribution Channel
    10.2.6.4 Spain Metabolism Drugs Market
    10.2.6.4.1 Spain Metabolism Drugs Market by Therapy Type
    10.2.6.4.2 Spain Metabolism Drugs Market by Application
    10.2.6.4.3 Spain Metabolism Drugs Market by Distribution Channel
    10.2.6.5 United Kingdom Metabolism Drugs Market
    10.2.6.5.1 United Kingdom Metabolism Drugs Market by Therapy Type
    10.2.6.5.2 United Kingdom Metabolism Drugs Market by Application
    10.2.6.5.3 United Kingdom Metabolism Drugs Market by Distribution Channel
    10.2.6.6 Rest of Europe Metabolism Drugs Market
    10.2.6.6.1 Rest of Europe Metabolism Drugs Market by Therapy Type
    10.2.6.6.2 Rest of Europe Metabolism Drugs Market by Application
    10.2.6.6.3 Rest of Europe Metabolism Drugs Market by Distribution Channel
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Metabolism Drugs Market Overview
    10.3.2 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis
    10.3.3 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
    10.3.4 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis - By Application
    10.3.5 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
    10.3.6 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Metabolism Drugs Market
    10.3.6.1.1 Australia Metabolism Drugs Market by Therapy Type
    10.3.6.1.2 Australia Metabolism Drugs Market by Application
    10.3.6.1.3 Australia Metabolism Drugs Market by Distribution Channel
    10.3.6.2 China Metabolism Drugs Market
    10.3.6.2.1 China Metabolism Drugs Market by Therapy Type
    10.3.6.2.2 China Metabolism Drugs Market by Application
    10.3.6.2.3 China Metabolism Drugs Market by Distribution Channel
    10.3.6.3 India Metabolism Drugs Market
    10.3.6.3.1 India Metabolism Drugs Market by Therapy Type
    10.3.6.3.2 India Metabolism Drugs Market by Application
    10.3.6.3.3 India Metabolism Drugs Market by Distribution Channel
    10.3.6.4 Japan Metabolism Drugs Market
    10.3.6.4.1 Japan Metabolism Drugs Market by Therapy Type
    10.3.6.4.2 Japan Metabolism Drugs Market by Application
    10.3.6.4.3 Japan Metabolism Drugs Market by Distribution Channel
    10.3.6.5 South Korea Metabolism Drugs Market
    10.3.6.5.1 South Korea Metabolism Drugs Market by Therapy Type
    10.3.6.5.2 South Korea Metabolism Drugs Market by Application
    10.3.6.5.3 South Korea Metabolism Drugs Market by Distribution Channel
    10.3.6.6 Rest of Asia-Pacific Metabolism Drugs Market
    10.3.6.6.1 Rest of Asia-Pacific Metabolism Drugs Market by Therapy Type
    10.3.6.6.2 Rest of Asia-Pacific Metabolism Drugs Market by Application
    10.3.6.6.3 Rest of Asia-Pacific Metabolism Drugs Market by Distribution Channel
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Metabolism Drugs Market Overview
    10.4.2 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis
    10.4.3 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
    10.4.4 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis - By Application
    10.4.5 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
    10.4.6 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Metabolism Drugs Market
    10.4.6.1.1 South Africa Metabolism Drugs Market by Therapy Type
    10.4.6.1.2 South Africa Metabolism Drugs Market by Application
    10.4.6.1.3 South Africa Metabolism Drugs Market by Distribution Channel
    10.4.6.2 Saudi Arabia Metabolism Drugs Market
    10.4.6.2.1 Saudi Arabia Metabolism Drugs Market by Therapy Type
    10.4.6.2.2 Saudi Arabia Metabolism Drugs Market by Application
    10.4.6.2.3 Saudi Arabia Metabolism Drugs Market by Distribution Channel
    10.4.6.3 U.A.E Metabolism Drugs Market
    10.4.6.3.1 U.A.E Metabolism Drugs Market by Therapy Type
    10.4.6.3.2 U.A.E Metabolism Drugs Market by Application
    10.4.6.3.3 U.A.E Metabolism Drugs Market by Distribution Channel
    10.4.6.4 Rest of Middle East and Africa Metabolism Drugs Market
    10.4.6.4.1 Rest of Middle East and Africa Metabolism Drugs Market by Therapy Type
    10.4.6.4.2 Rest of Middle East and Africa Metabolism Drugs Market by Application
    10.4.6.4.3 Rest of Middle East and Africa Metabolism Drugs Market by Distribution Channel
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Metabolism Drugs Market Overview
    10.5.2 South and Central America Metabolism Drugs Market Forecasts and Analysis
    10.5.3 South and Central America Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
    10.5.4 South and Central America Metabolism Drugs Market Forecasts and Analysis - By Application
    10.5.5 South and Central America Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
    10.5.6 South and Central America Metabolism Drugs Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Metabolism Drugs Market
    10.5.6.1.1 Brazil Metabolism Drugs Market by Therapy Type
    10.5.6.1.2 Brazil Metabolism Drugs Market by Application
    10.5.6.1.3 Brazil Metabolism Drugs Market by Distribution Channel
    10.5.6.2 Argentina Metabolism Drugs Market
    10.5.6.2.1 Argentina Metabolism Drugs Market by Therapy Type
    10.5.6.2.2 Argentina Metabolism Drugs Market by Application
    10.5.6.2.3 Argentina Metabolism Drugs Market by Distribution Channel
    10.5.6.3 Rest of South and Central America Metabolism Drugs Market
    10.5.6.3.1 Rest of South and Central America Metabolism Drugs Market by Therapy Type
    10.5.6.3.2 Rest of South and Central America Metabolism Drugs Market by Application
    10.5.6.3.3 Rest of South and Central America Metabolism Drugs Market by Distribution Channel

    11. INDUSTRY LANDSCAPE
    11.1. MERGERS AND ACQUISITIONS
    11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    11.3. NEW PRODUCT LAUNCHES
    11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    12. METABOLISM DRUGS MARKET, KEY COMPANY PROFILES
    12.1. MERCK SHARP AND DOHME CORP
    12.1.1. Key Facts
    12.1.2. Business Description
    12.1.3. Products and Services
    12.1.4. Financial Overview
    12.1.5. SWOT Analysis
    12.1.6. Key Developments
    12.2. NOVARTIS AG
    12.2.1. Key Facts
    12.2.2. Business Description
    12.2.3. Products and Services
    12.2.4. Financial Overview
    12.2.5. SWOT Analysis
    12.2.6. Key Developments
    12.3. AMICUS THERAPEUTICS
    12.3.1. Key Facts
    12.3.2. Business Description
    12.3.3. Products and Services
    12.3.4. Financial Overview
    12.3.5. SWOT Analysis
    12.3.6. Key Developments
    12.4. ASTRAZENECA
    12.4.1. Key Facts
    12.4.2. Business Description
    12.4.3. Products and Services
    12.4.4. Financial Overview
    12.4.5. SWOT Analysis
    12.4.6. Key Developments
    12.5. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    12.5.1. Key Facts
    12.5.2. Business Description
    12.5.3. Products and Services
    12.5.4. Financial Overview
    12.5.5. SWOT Analysis
    12.5.6. Key Developments
    12.6. TAKEDA PHARMACEUTICAL COMPANY LIMITED
    12.6.1. Key Facts
    12.6.2. Business Description
    12.6.3. Products and Services
    12.6.4. Financial Overview
    12.6.5. SWOT Analysis
    12.6.6. Key Developments
    12.7. SANOFI
    12.7.1. Key Facts
    12.7.2. Business Description
    12.7.3. Products and Services
    12.7.4. Financial Overview
    12.7.5. SWOT Analysis
    12.7.6. Key Developments
    12.8. GLAXOSMITHKLINE PLC
    12.8.1. Key Facts
    12.8.2. Business Description
    12.8.3. Products and Services
    12.8.4. Financial Overview
    12.8.5. SWOT Analysis
    12.8.6. Key Developments
    12.9. HORIZON THERAPEUTICS
    12.9.1. Key Facts
    12.9.2. Business Description
    12.9.3. Products and Services
    12.9.4. Financial Overview
    12.9.5. SWOT Analysis
    12.9.6. Key Developments
    12.10. BIOMARIN PHARMACEUTICAL
    12.10.1. Key Facts
    12.10.2. Business Description
    12.10.3. Products and Services
    12.10.4. Financial Overview
    12.10.5. SWOT Analysis
    12.10.6. Key Developments

    13. APPENDIX
    13.1. ABOUT THE INSIGHT PARTNERS
    13.2. GLOSSARY OF TERMS
    The List of Companies

    1. Merck Sharp and Dohme Corp
    2. Novartis AG
    3. Amicus Therapeutics
    4. AstraZeneca
    5. Boehringer Ingelheim International GmbH
    6. Takeda Pharmaceutical Company Limited
    7. Sanofi
    8. GlaxoSmithKline Plc
    9. Horizon Therapeutics
    10. BioMarin Pharmaceutical
    TIPRE00004056
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking